TrialThe New England journal of medicine2015

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.